Vertical transmission of Babesia microti, United States.
Disease transmission (Health aspects)
Infection (Health aspects)
Joseph, Julie T.
Wong, Susan J.
Horowitz, Harold W.
Aguero-Rosenfeld, Maria E.
Moore, Julie M.
Wormser, Gary P.
|Publication:||Name: Emerging Infectious Diseases Publisher: U.S. National Center for Infectious Diseases Audience: Academic; Professional Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2012 U.S. National Center for Infectious Diseases ISSN: 1080-6040|
|Issue:||Date: August, 2012 Source Volume: 18 Source Issue: 8|
|Product:||Product Code: 2831812 Deoxyribonucleic Acid NAICS Code: 325414 Biological Product (except Diagnostic) Manufacturing|
|Geographic:||Geographic Scope: New York Geographic Code: 1U2NY New York|
Babesiosis is an emerging infection in the United States,
principally caused by Babesia microti (1). The most common route of
infection is the bite of an Ixodes scapularis tick; transmission can
also occur by transfusion of infected blood products, and vertical
transmission in animals has been documented (2,3) and is a potential
route of transmission for humans. We report a case of babesiosis in an
infant for whom vertical transmission was suggested by Babesia spp.
antibodies in a heel spot blood sample and confirmed by detection of
Babesia DNA in placenta tissue.
A 6-week-old girl from Yorktown Heights, New York, was admitted to the hospital on September 16, 2002, with a 2-day history of fever, irritability, and decreased oral intake. The mother was asymptomatic during and after her pregnancy. The infant was delivered vaginally and full term at 3,430 g without complications. The infant's mother had visited parks in Westchester and Dutchess Counties in New York during the pregnancy but was unaware of any tick bites. The infant had no known tick exposure, and neither mother nor infant had a history of blood transfusion.
During examination, the infant was alert but irritable and pale. Axillary temperature was initially 36.8[degrees]C but increased to 38.1[degrees]C on the same day. Her conjunctivae were icteric, she had a palpable spleen tip, and her liver was palpable 3 cm below the costal margin. Initial laboratory findings included hemoglobin 7.1 g/dL, platelet count 100 x [10.sup.3]/[micro]L, and leukocyte count 19.7 x [10.sup.3] cells/[micro]L with a differential of 4% segmented neutrophils, 80% lymphocytes, and 16% monocytes. Reticulocyte count was 5.5%. Total bilirubin concentration was 2 mg/dL with a direct fraction of 0.4 mg/dL; aspartate aminotransferase level was 66 U/L, alanine aminotransferase level was 50 U/L, and alkaline phosphatase level was 339 U/L. Cultures of blood, urine, and cerebrospinal fluid samples yielded negative results. Lyme disease serologic test result was negative.
Routine examination of a peripheral blood smear showed B. microti in 4% of erythrocytes (Figure); a blood sample from the infant was positive by PCR for B. microti DNA. Total B. microti antibody titer was > 256 by indirect immunofluorescence assay, with a polyvalent secondary antibody (anti-IgG+IgA+IgM) (4) that was presumed to be principally IgG because test results for IgM were negative (online Technical Appendix, wwwnc.cdc.gov/EID/ pdfs/11-0988-Techapp.pdf). The heel-stick blood sample obtained on the infant's third day of life as part of newborn screening was tested and found to be negative for B. microti by PCR (5) and for IgM but total antibody positive (> 128) (online Technical Appendix).
Examination of the placenta showed focal basal decidual inflammation, mild chorangiosis, and villus dys-maturity. Babesia spp. piroplasms were not detected in maternal or fetal blood by histologic examination of hematoxylin and eosin-stained sections of formalin-fixed, paraffin-embedded tissue of the placenta disk, amnion/ chorion, and umbilical cord. Babesia DNA was detected by real-time PCR testing of paraffin-embedded placenta tissue (online Technical Appendix) (6). Cycle threshold values were relatively high (37.1-38.2), indicating that the amount of parasite DNA in the sample was close to the limit of detection; results were reproducible on duplicate testing of DNA samples extracted from separate paraffin blocks. The real-time PCR product was of the correct size, and the melting curve demonstrated melting temperatures within 1[degrees]C from the placenta, the positive control, and a positive sample from an unrelated patient, confirming that the correct product was amplified. At time of the illness in the infant, the mother was negative for Babesia spp. according to PCR and smear but positive for total antibodies (> 256).
The infant was treated with a 9-day course of azithromycin plus atovaquone. A blood transfusion was administered when her hemoglobin concentration fell to 5.2 g/dL. The infant became afebrile by 72 hours and was discharged after a 5-day hospitalization. Repeat blood smears revealed a parasite load of 0.3% at discharge. On final evaluation at 22 months of age, physical examination revealed no abnormalities; hemoglobin level was 11.7 g/dL, Babesia PCR was negative, and total Babesia antibody level was positive at 128.
Congenital babesiosis has been rarely reported (Table) (7-10). This case provided convincing evidence for congenital babesiosis because of prepartum infection involving the placenta in the mother. On the basis of experience with congenital malaria, we assume that Babesia spp. parasites cross the placenta during pregnancy or at the time of delivery (11,12). In congenital malaria, increasing evidence suggests that the malaria parasites are most often acquired antenatally by transplacental transmission of infected erythrocytes (12).
We found Babesia spp. antibodies on day 3 of life by analyzing the patient's heel-stick blood sample, which likely represented maternal transfer of IgG. Passive transfer of maternal antibodies is regarded as a protective factor against congenital malaria, and some newborns with malaria who are parasitemic at birth spontaneously clear the infection without ever becoming ill (11,14). The temporary presence of maternal IgG in infants has been suggested as an explanation for the typical 3-6 week incubation period of congenital malaria in non-disease endemic areas (14).
The real-time PCR used to find B. microti DNA in placenta tissue is [approximately equal to] 20x more sensitive than microscopic examination of Giemsa-stained blood smears (6). Assuming a blood sample with a parasitemia equivalent to that detected in the placental tissue, a blood smear would contain [less than or equal to] 10 infected cells per slide. Given the low level of Babesia DNA in the placenta tissue, it is not surprising that histologic examination did not reveal piroplasms. Nonetheless, limited evidence of placental abnormalities suggests a pathologic process.
In summary, babesiosis is an emerging infectious disease (15) that can rarely cause congenital infection. This diagnosis should be considered in the differential diagnosis of fever and hemolytic anemia in infants from diseaseendemic areas.
The authors thank Steven Smith, Jennifer Calder, Lisa Giarratano, Lenise Banwarie, Ewa Bajor-Dattilo, and Karen Kulas for their assistance.
(1.) Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22:469-88. http://dx.doi.org/10.1016/j. idc.2008.03.010
(2.) de Vos AJ, Imes GD, Cullen JSC. Cerebral babesiosis in a new-born calf. Onderstepoort J Vet Res. 1976;43:75-8.
(3.) Fukumoto S, Suzuki H, Igarashi I, Xuan X. Fatal experimental transplacental Babesia gibsoni infections in dogs. Int J Parasitol. 2005;35:1031-5. http://dx.doi.org/10.1016/j.ijpara.2005.03.018
(4.) Chisholm ES, Ruebush TK II, Sulzer AJ, Healy GR. Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg. 1978;27:14-9.
(5.) Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomfod JW, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. 1992;30:2097-103.
(6.) Teal AE, Habura A, Ennis J, Keithly J, Madison-Antenucci S. A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol. 2012;50:903-8. http://dx.doi.org/10.1128/ JCM.05848-11
(7.) Esernio-Jenssen D, Scimeca PG, Benach JL, Tenenbaum MJ. Transplacental/perinatal babesiosis. J Pediatr. 1987;110:570-2. http:// dx.doi.org/10.1016/S0022-3476(87)80552-8
(8.) New DL, Quinn J, Qureshi MZ, Sigler S. Vertically transmitted babesiosis. J Pediatr. 1997;131:163-4. http://dx.doi.org/10.1016/ S0022-3476(97)70143-4
(9.) Sethi S, Alcid D, Kesarwala H, Tolan RW Jr. Probable congenital babesiosis in infant, New Jersey, USA. Emerg Infect Dis. 2009;15:788-91. http://dx.doi.org/10.3201/eid1505.070808
(10.) Aderinboye O, Syed S. Congenital babesiosis in a four-week old female infant. Pediatr Infect Dis J. 2010;29:188. http://dx.doi. org/10.1097/INF.0b013e3181c3c971
(11.) Vottier G, Arsac M, Farnoux C, Mariani-Kurddjian P, Baud O, Aujard Y. Congenital malaria in neonates: two case reports and review of the literature. Acta Paediatr. 2008;97:505-8. http://dx.doi. org/10.1111/j.1651-2227.2008.00690.x
(12.) Malhotra I, Mungai P, Muchiri E, Kwiek JJ, Meshnick SR, King CL. Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya. J Infect Dis. 2006;194:176-83. http://dx.doi.org/10.1086/505150
(13.) Lesko CR, Arguin PM, Newman RD. Congenital malaria in the United States. A review of cases from 1966 to 2005. Arch Pediatr Ado lesc Med. 2007;161:1062-7. http://dx.doi.org/10.1001/archpedi. 161.11.1062
(14.) Hagmann S, Khanna K, Niazi M, Purswani M, Robins EB. Congenital malaria, an important differential diagnosis to consider when evaluating febrile infants of immigrant mothers. Pedi atr Emerg Care. 2007;23:326-9. http://dx.doi.org/10.1097/01. pec.0000270164.78238.7d
(15.) Joseph JT, Roy SS, Shams N, Visintainer P, Nadelman RB, Hosur S, et al. Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis. 2011;17:843-7.
Dr Joseph is an assistant professor of medicine in the Division of Infectious Diseases at New York Medical College. Her research interests are tick-borne illnesses, particularly babesiosis.
Address for correspondence: Julie T. Joseph, New York Medical College, Division of Infectious Diseases, Munger Pavilion Room 245, Valhalla, NY 10595, USA; email: email@example.com
Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the US Department of Health and Human Services.
Julie T. Joseph, Kerry Purtill, Susan J. Wong, Jose Munoz, Allen Teal, Susan Madison-Antenucci, Harold W. Horowitz,  Maria E. Aguero-Rosenfeld,  Julie M. Moore, Carlos Abramowsky, and Gary P. Wormser
 Current affiliation: New York University School of Medicine, New York, New York, USA.
Author affiliations: New York Medical College, Valhalla, New York, USA (J.T. Joseph, K. Purtill, J. Munoz, H.W. Horowitz, M.E. Aguero-Rosenfeld, G.P. Wormser); New York State Department of Health, Albany, New York, USA (S.J. Wong, A. Teal, S. Madison-Antenucci); University of Georgia, Athens, Georgia, USA (J.M. Moore); and Emory University School of Medicine, Atlanta, Georgia, USA (C. Abramowsky)
Table. Comparison of selected clinical and laboratory data from reported cases of congenital babesiosis in 5 infants * Reference Clinical data (7) Year of diagnosis/ Not given/Long Island, location New York Infant age at time of 30 symptom onset, d Clinical findings Fever, irritability, pallor, hepatosplenomegaly Initial babesia 5 parasitemia level, % Hospitalization, d 6 Maternal tick bite 1 wk before delivery Babesia spp. 30 d after birth: serologic and PCR IgM+/IgG+ (128/128) results for infant by IFA; 32 d after birth: IgM+/IgG+ (256/512) by IFA; PCR ND Babesia spp. 30 d after birth: evaluation results IgM+/IgG+ for mother (2,048/1,024); 32 d after birth: IgM+/ IgG+ (4,096/1,024); peripheral smear--at time of delivery and at 30 and 32 d after birth HGB, g/dL 9.3 Platelets, x [10.sup.3]/ 38 [micro]L Leukocytes/PMN 6,500/1,170 leukocytes, cells/[micro]L LDH, U/L 894 Bilirubin indirect, 3.6 mg/dL AST, U/L 90 ALT, U/L 90 Treatment CLI and quinine for 10 d Follow-up Well at 6 mo posttreatment Blood transfusion for Yes, for HCT of 18% anemia Reference Clinical data (8) Year of diagnosis/ Not given/Long Island, location New York Infant age at time of 32 symptom onset, d Clinical findings Fever, lethargy, poor feeding, pallor, scleral icterus, hepatomegaly Initial babesia 4.4 parasitemia level, % Hospitalization, d 5 Maternal tick bite 7 wk before delivery Babesia spp. At illness onset: IgG IFA serologic and PCR 160; IgM/IgG results for infant immunoblot +; PCR ND Babesia spp. 7 wk before birth: IgG evaluation results IFA <40; IgM/IgG for mother immunoblot -; 2 mo after birth: IgG IFA 640; IgM/IgG immunoblot +; peripheral smear--at delivery and at infant illness onset HGB, g/dL 10.8 Platelets, x [10.sup.3]/ 87 [micro]L Leukocytes/PMN NA leukocytes, cells/[micro]L LDH, U/L NA Bilirubin indirect, 9.7 mg/dL AST, U/L NA ALT, U/L NA Treatment CLI and quinine with AZT added on day 3; on day 5 changed to AZT plus quinine for additional 7 d Follow-up Improved at 2 wk Blood transfusion for Yes, for HGB of 7.3 g/dL anemia Reference Clinical data (9) (10) Year of diagnosis/ Not given/New Not given/Long location Jersey Island, New York Infant age at time of 19 27 symptom onset, d Clinical findings Fever, poor Fever, pallor feeding, gagging, irritability, pallor, scleral icterus, hepato- splenomegaly Initial babesia 15 2 parasitemia level, % Hospitalization, d 8 NA Maternal tick bite 4 wk before None known delivery Babesia spp. At illness onset: NA serologic and PCR IgM+/IgG+ results for infant (40/256) by IFA; PCR ND Babesia spp. At infant illness At infant illness evaluation results onset: IgM+/IgG+ onset: PCR+ for mother (80/>1,024) by IFA; peripheral smear negative at time of infant illness onset HGB, g/dL 8.8 NA; HCT 24.3% Platelets, x [10.sup.3]/ 34 101 [micro]L Leukocytes/PMN 9,000/1,890 NA leukocytes, cells/[micro]L LDH, U/L 2535 NA Bilirubin indirect, 5.9 NA mg/dL AST, U/L 53 NA ALT, U/L 18 NA Treatment AZT and ATO for AZT and ATO, 10 d duration not given Follow-up Lost to follow-up NA Blood transfusion for Yes, for HGB of Yes, for HCT of anemia 7.0 g/dL 17.3% Reference Clinical data This study Year of diagnosis/ 2002/Westchester location County, New York Infant age at time of 41 symptom onset, d Clinical findings Fever, decreased oral intake, irritability, scleral icterus, pallor, hepatosplenomegaly Initial babesia 4 parasitemia level, % Hospitalization, d 5 Maternal tick bite None known Babesia spp. Newborn screening serologic and PCR (heel stick): IgM- results for infant (<16); total antibody + (>128) by IFA; PCR-; 6 wks after birth: IgM- (<16); total antibody + (>256) by IFA; PCR+ Babesia spp. Birth: placenta PCR+; evaluation results 6 wk after birth: IgM for mother ND; total antibody + (>256) by IFA; PCR-; peripheral smear - HGB, g/dL 7.1 Platelets, x [10.sup.3]/ 100 [micro]L Leukocytes/PMN 19,700/788 leukocytes, cells/[micro]L LDH, U/L NA Bilirubin indirect, 1.6 mg/dL AST, U/L 66 ALT, U/L 50 Treatment AZT and ATO for 9 d Follow-up 22 mo Blood transfusion for Yes, for HGB of 5.2 anemia g/dL with HCT of 15.8% * No mothers became ill. NA, not available; +, positive; IFA, indirect immunofluorescence assay; ND, not done; -, negative; HGB, hemoglobin; HCT, hematocrit; PMN, polymorphonuclear; LDH, lactate dehydrogenase level; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CLI, clindamycin; AZT, azithromycin; ATO, atovaquone.
|Gale Copyright:||Copyright 2012 Gale, Cengage Learning. All rights reserved.|